Table 1.

Clinical presentation and outcomes of all cases

Case	Sex	Age	HTLV-1	Comorbidities	CSF culture	Blood culture	Strongyloides	Gastrointestinal symptoms	Respiratory symptoms	Antihelminthics	Outcome
1	F	21	(+)	Ototitis media	E. coli	Negative	Stool			Thiabendazole	Recovery
		31			E. coli	Negative	Stool, gastric juice	Abdominal distention		Thiabendazole	Recovery
		38			L. lactis	L. lactis	Stool	Weight loss, appetite loss, diarrhea	dry cough	Thiabendazole	Recovery
		40			S. bovis	S. bovis	Stool			Thiabendazole, Ivermectin	Recovery
2	M	38	(+)	HBV infection	S. sanguinis	Negative	Stool	Diarrhea		Thiabendazole	Recovery
		43			Negative	Negative	Stool	Weight loss, diarrhea		Thiabendazole	Recovery
		45			Negative	Negative	Stool	Diarrhea		Thiabendazole	Recovery
		45			Negative	Negative	Negative	Diarrhea		Thiabendazole	Recovery
		46			Negative	Negative	Stool			Thiabendazole	Recovery
		49			Negative	Negative	Stool, sputum	Weight loss	Hemoptysis	Ivermectin	Recovery
3	F	60	(+)	Cervical cancer	Negative	Negative	Stool			Thiabendazole	Recovery
		60			E. coli	Negative	Negative			Thiabendazole	Recovery
		62			Negative	E. coli	Stool			Thiabendazole	Recovery
		63			E. coli	E. coli	Negative			Thiabendazole	Recovery
		64			Negative	Negative	Negative			Thiabendazole	Recovery
		65			Negative	E. coli	Negative			Thiabendazole, Ivermectin	Recovery
4	M	76	(+)	Smoldering ATL	Negative	K. pneumonia	Stool, gastric juice			Thiabendazole	Recovery
		76			K. pneumonia	K. pneumonia	Negative			Thiabendazole	Death
5	M	49	(+)		Negative	Negative	Not performed			None	Recovery
		49			S. bovis	Negative	Stool	Diarrhea	Sore throat, wet cough	Ivermectin	Recovery

HTLV-1 = human T-lymphotropic virus type 1; HBV = hepatitis B virus; ALT = adult T-cell leukemia.